p53, mutation frequency and apoptosis in the murine small intestine

Oncogene
A R ClarkeD J Winton

Abstract

Normal function of the p53 gene is integral to the cellular response to genotoxic stress. One prediction arising from this is that p53 deficiency results in an increased mutation frequency. However, limited evidence has been produced in support of this idea. In order to further investigate the in vivo role of p53 in surveillance against mutation, and particularly to address the significance of p53-dependent apoptosis, we scored mutation frequency at the Dlb-1 locus within cells of the intestinal epithelium of animals which were wild type, heterozygous or null for p53 and heterozygous (a/b) at the Dlb-1 locus. Using this assay we have shown that loss of a p53-dependent apoptotic pathway is associated with the detectable acquisition of mutations, but only at high levels of DNA damage. These results question the significance of the immediate 'wave' of p53-dependent apoptosis seen in this tissue, particularly as there was a delayed p53-independent apoptotic pathway. We conclude that loss of p53 function only becomes relevant to the in vivo acquisition of mutations and thus tumorigenesis in certain circumstances.

Citations

Oct 12, 2000·Mutation Research·O J Sansom, A R Clarke
May 9, 2002·Mutation Research·Li LiangJay A Tischfield
Feb 18, 1999·Toxicology Letters·D J Harrison
Jun 11, 1999·Immunology and Cell Biology·D Watters
Mar 21, 2001·Biotechnology & Genetic Engineering Reviews·E S Hickman, K Helin
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·C ShaoJ A Tischfield
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C ShaoJ A Tischfield
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·N J ToftA R Clarke
Dec 9, 2004·Biochimica Et Biophysica Acta·Joanna Zabkiewicz, Alan R Clarke
Aug 27, 2016·Scientific Reports·Nadia RuoccoLuigia Santella
Feb 26, 2000·Carcinogenesis·S P BachC S Potten
Sep 26, 1997·Nature·A Wyllie
Feb 26, 2016·PloS One·Stefano VarrellaMaria Costantini
Apr 30, 2003·Cell Death and Differentiation·A R Clarke, M Hollstein
Nov 10, 2013·PloS One·Chin Wee TanAntony W Burgess
Aug 8, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·M Agostina SantoroP Kay Lund
Mar 21, 2008·American Journal of Physiology. Cell Physiology·Stephen H K WongKai Y Lei
Mar 31, 2000·Cell Proliferation·L RoncucciA De Pol
Jan 25, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·A J Watson, D M Pritchard
Oct 14, 2003·The Journal of Experimental Biology·Michael P LesserThomas M Barry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis